Back to News
Sep 25, 2025 12:10 PM

OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025

OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025

Nantes, France, September 25, 2025, 6 p.m. CET - OSE Immunotherapeutics SA (SGMX:OSEp(SGMX:OSEpSGMX:OSEpISGMX:OSEpSSGMX:OSEpISGMX:OSEpNSGMX:OSEp:SGMX:OSEp SGMX:OSEpFSGMX:OSEpRSGMX:OSEp0SGMX:OSEp0SGMX:OSEp1SGMX:OSEp2SGMX:OSEp1SGMX:OSEp2SGMX:OSEp7SGMX:OSEp1SGMX:OSEp7SGMX:OSEp3SGMX:OSEp;SGMX:OSEp SGMX:OSEpMSGMX:OSEpnSGMX:OSEpeSGMX:OSEpmSGMX:OSEpoSGMX:OSEp:SGMX:OSEp SGMX:OSEpOSGMX:OSEpSSGMX:OSEpESGMX:OSEp)SGMX:OSEp, Mnemo: OSE)) reports its cash position as of June 30, 2025. Due to the Company's Annual General Meeting being rescheduled to September 30, 2025, and to allow shareholders to first approve 2024 financial statements, the full 2025 half-year interim financial results will be published on October 15, 2025.